This is the authors' abstract. We don't add key points for this paper.
In patients with rectal cancer who receive preoperative radiotherapy, adding fluorouracil-based chemotherapy preoperatively or postoperatively has no significant effect on survival. Chemotherapy, regardless of whether it is administered before or after surgery, confers a significant benefit with respect to local control. (ClinicalTrials.gov number, NCT00002523 [ClinicalTrials.gov].).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bosset et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: